[Federal Register Volume 79, Number 130 (Tuesday, July 8, 2014)]
[Notices]
[Page 38564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-15888]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: S & B
PHARMA, INC.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before September 8, 2014.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, and dispensers of controlled substances
(other than final orders in connection with suspension, denial, or
revocation of registration) has been redelegated to the Deputy
Assistant Administrator of the DEA Office of Diversion Control
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR
pt. 0, subpt. R, App.
In accordance with 21 CFR 1301.33(a), this is notice that on
December 10, 2013, S & B Pharma, Inc., DBA Norac Pharma, 405 South
Motor Avenue, Azusa, California 91702-3232, applied to be registered as
a bulk manufacturer of the following basic classes of narcotic or
nonnarcotic controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric (2010)................ I
Tetrahydrocannabinols (7370)............... I
Methamphetamine (1105)..................... II
Pentobarbital (2270)....................... II
Nabilone (7379)............................ II
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Tapentadol (9780).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for use in product development and for commercial sales to its
customers.
Dated: July 1, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-15888 Filed 7-7-14; 8:45 am]
BILLING CODE 4410-09-P